Akums Drugs and Pharma Gets CDSCO Panel Nod to study Aceclofenac plus Drotaverine Hydrochloride tablet Dr. Divya Colin2 Aug 2024 6:00 PM ISTNew Delhi: The drug major Akums Drugs and Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
Akums Drugs and Pharmaceuticals Gets CDSCO Panel Nod To study Dapagliflozin plus Bisoprolol FDC Dr. Divya Colin12 Jun 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to the...
CDSCO Panel Rejects Akum Pharma's Clonazepam-Duloxetine Combination Drug Dr. Divya Colin18 March 2024 6:00 PM ISTNew Delhi: Reviewing the justification provided by the drug major Akum Pharmaceutical concerning the fixed-dose combination (FDC) Clonazepam plus...
Akums Drugs and Pharma files draft IPO papers with Sebi Ruchika Sharma12 Feb 2024 11:30 AM ISTThe company is looking to raise Rs 136 crore through a pre-IPO placement.
No safety data available, Conduct Phase-III CT: CDSCO Panel Tells Akums on Norethindrone, Estradiol, Relugolix film-coated tablet Dr. Divya Colin12 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Revise BE study Protocol: CDSCO Panel Tells Akum Pharma on Chlorthalidone, Cilnidipine, Bisoprolol FDC Dr. Divya Colin24 Dec 2023 6:00 PM ISTNew Delhi: Citing that individual and innovators products should be taken as a reference product in the proposed bioequivalence (BE) study protocol,...
Akums Drugs & Pharma acquires new formulation facility in Baddi Ruchika Sharma6 Dec 2023 4:30 PM ISTHimachal Pradesh: Akums Drugs & Pharmaceuticals has said it has acquired a new formulation facility located in Baddi, Himachal Pradesh.The plant,...
Akum Pharma Gets CDSCO Panel Nod to Study Cetirizine Ophthalmic Solution Dr. Divya Colin9 Oct 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO Panel Tells Akums to submit rationale for FDC Bempedoic acid, Atorvastatin, Ezetimibe film-coated tablet Dr. Divya Colin23 Sept 2023 6:00 PM ISTNew Delhi: Responding to the proposal presented by the drug major Akum Pharmaceuticals regarding the fixed-dose combination drug containing Bempedoic...
Akums Pharma Gets CDSCO Panel Nod To Manufacture, Market Estradiol, Progesterone FDC soft gelatin capsule Dr. Divya Colin16 Sept 2023 6:00 PM ISTNew Delhi: Granting for Phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Akums gets approval for triple combination diabetes treatment Ruchika Sharma27 July 2023 4:50 PM ISTDelhi: Akums Drugs and Pharmaceuticals Limited has secured approval for its triple combination diabetes treatment. Sitagliptin 100, Pioglitazone 15...
More clinical trial sites should be included: CDSCO Panel tells Akum Pharma over Letrozole tablet Dr. Divya Colin11 July 2023 6:00 PM ISTNew Delhi: Noting more clinical trial sites should be included to have geographically distributed sites across India, the Subject Expert Committee...
